STATE INSTITUTION CENTER FOR PHARMACEUTICAL PRODUCTS SAFETY UNDER THE MINISTRY OF HEALTH OF THE REPUBLIC OF UZBEKISTAN

Company Type: Regulatory Agency

The State Institution Center for Pharmaceutical Products Safety under the Ministry of Health of the Republic of Uzbekistan is a governmental organization. Its primary function is to ensure the safety, quality, and efficacy of pharmaceutical products, medical devices, and other healthcare-related goods within the Republic of Uzbekistan.

This institution acts as a key regulatory body. It is responsible for expert assessment, registration, certification, quality control, and post-market surveillance of medicinal products. The Center conducts laboratory analyses, inspections, and monitoring to verify compliance with national and international standards and regulations. Its mission is to protect public health by preventing the circulation of substandard, counterfeit, or unsafe pharmaceutical products.

It is neither a factory that manufactures products nor a trading company that buys or sells them. Instead, it serves as a public authority overseeing and regulating the pharmaceutical sector to safeguard consumer welfare and maintain the integrity of the healthcare system.

Unfortunately, I don't have access to a real-time, comprehensive database of specific product listings for the STATE INSTITUTION CENTER FOR PHARMACEUTICAL PRODUCTS SAFETY UNDER THE MINISTRY OF HEALTH OF THE REPUBLIC OF UZBEKISTAN. This type of information is often proprietary or only available through official channels.

However, I can provide some general information based on the company's function:

The STATE INSTITUTION CENTER FOR PHARMACEUTICAL PRODUCTS SAFETY UNDER THE MINISTRY OF HEALTH OF THE REPUBLIC OF UZBEKISTAN is likely involved in:

* **Evaluation and registration of pharmaceutical products:** This means they would be assessing the safety and efficacy of drugs seeking approval for sale in Uzbekistan.

* **Quality control of pharmaceutical products:** They would be testing and ensuring the quality of drugs already on the market.

* **Pharmacovigilance:** This involves monitoring the safety of drugs after they are marketed and taking action if necessary.

* **Licensing and certification:** They might be involved in issuing licenses and certifications related to pharmaceutical manufacturing and distribution.

Therefore, they would not directly *manufacture* pharmaceutical products. Instead, their role is to *evaluate, control, and monitor* the safety and quality of pharmaceutical products manufactured by other companies that are intended for use within Uzbekistan.